Meridian Health Ventures
VC Fund
London, United Kingdom
Meridian Health Ventures is a VC fund in London focused on Health Care and Medical Device. KHP Ventures is an investment firm that provides innovative ideas for healthcare.
- Total investments:
- 30
- Last investment:
- Lead investor:
- 23%
Last updated:
For AI agents: llms.txt
Industries Meridian Health Ventures invests in
Stages Meridian Health Ventures invests in
Countries Meridian Health Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
1 more contact available
Round size
- Seed
- $1.5M–$6.5M
- Series A
- $9M–$23M
Investment Focus
Industry
- Health Care 18 (60%)
- Medical Device 8 (27%)
- Medical 6 (20%)
- Artificial Intelligence 6 (20%)
- Hospital 4 (13%)
Stage
- Seed 10 (33%)
- Series A 6 (20%)
- Funding Round 4 (13%)
- Venture - Series Unknown 3 (10%)
- Pre-Seed 1 (3%)
Country
- United Kingdom 17 (57%)
- Sweden 1 (3%)
- Germany 1 (3%)
- United States 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Daniel Dickens
Managing Partner
|
Managing Partner | Total investments: 5 | Find email | |
Jing Wei Luo
Head of Legal and Operations
|
Head of Legal and Operations | Total investments: 0 | Find email | |
|
Tim Irish
Partner
|
Partner | Total investments: 0 | Find email | |
Tim Irish
Partner
|
Partner | Total investments: 4 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
iFast Diagnostics
|
iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial resistance. | $3.9M / Seed / May 27, 2026 | |
JAAQ
|
JAAQ. is a mental health-focused online platform that allows users access to specialists and advocates. The company was founded in 2021 and is based in London, England. | $17.3M / Series A / Mar 23, 2026 | |
Klaris
|
Klaris automates the manual work medical device companies waste on regulatory documentation. Our first product is an AI Auditor with superhuman abilities. | $1M / Pre-Seed / Feb 17, 2026 | |
MediShout
|
MediShout is a digital platform to improve operational efficiencies, so healthcare staff can focus on patient care. MediShout brings calmness to chaotic wards and turns hospitals into smart and automated buildings. Our technology connects staff, systems, machines, and work-flow; thus improving efficiency and care. Our cloud-based technologyconnects people, Helpdesks, smartphones, tablets, IT systems, and RFID tagging. | $9M / Series A / Jul 02, 2025 | |
52 North Health
|
52 North Health aims to improve healthcare with a medical device that uses artificial intelligence (AI) to determine the risk of neutropenic sepsis for patients undergoing chemotherapy. | $6M / Dec 03, 2024 | |
PocDoc
|
PocDoc is a pioneer in the field of smartphone-based fast disease testing. | $6.2M / Seed / Nov 26, 2024 | |
|
iFast Diagnostics
|
iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial resistance. | $6.5M / Seed / Nov 04, 2024 | |
|
iFast Diagnostics
|
iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial resistance. | $6.5M / Seed / Nov 04, 2024 | |
deepc
|
Our vision: We strive to enable immediate access to precise and safe diagnostics for every person in the world. Building the Diagnostics OS - a cutting-edge web-based AI software framework, enabling medical professionals and AI companies to seamlessly integrate medical diagnostic AI and other digital products into the clinical workflow, such asin radiology - screening medical data in real-time, enhancing the diagnostic quality, and improving cost-efficiency.deepc was awarded the main prize by the Federal Ministry for Economic Affairs and Energy (BMWi) with both the Founder's Prize and the Special Prize in the field of healthcare | $13M / Series A / Jul 25, 2024 | |
Acorai
|
Acorai is developing a device for heart failure management through non-invasive intracardiac pressure monitoring (ICPM), to help reduce hospitalizations and readmissions. Our product, The Acorai Heart Monitor, can monitor mean pulmonary artery pressure (mPAP) non-invasively through a machine learning analysis of pressure dynamics in acoustics,vibratory and waveform data. Our technology show compelling precision, has a low-risk clinical and regulatory pathway, a low dependence on reimbursement and a fast track to commercialization. With a team with more than 50 years of industry experience, we can help heart failure patients live longer, healthier, and less uncertain lives.Acorai was founded in 2019 and is headquartered in Skane, Sweden. | $4.5M / Seed / Jan 19, 2024 | |
| See all 30 investments → | |||
Co-Investors
QantX
6 deals together
General Catalyst
4 deals together
Kadmos Capital
3 deals together
Macmillan Cancer Support
3 deals together
Praetura Ventures
3 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Meridian Health Ventures invest in?
Meridian Health Ventures invests primarily in Health Care, Medical Device and Medical startups, most often at Seed and Series A stage. Most of the 30 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Meridian Health Ventures's check size?
Meridian Health Ventures typically joins rounds of $1.5M–$6.5M at Seed and $9M–$23M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Meridian Health Ventures participates in.
How do I contact Meridian Health Ventures?
Public channels for Meridian Health Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Meridian Health Ventures?
The team at Meridian Health Ventures includes Daniel Dickens (Managing Partner), Jing Wei Luo (Head of Legal and Operations) and Tim Irish (Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
